Glycosylation Alterations in Cancer Cells, Prognostic Value of Glycan Biomarkers and Their Potential as Novel Therapeutic Targets in Breast Cancer

Although we are lately witnessing major improvements in breast cancer treatment and patient outcomes, there is still a significant proportion of patients not receiving efficient therapy. More precisely, patients with triple-negative breast cancer or any type of metastatic disease. Currently availabl...

Descripción completa

Detalles Bibliográficos
Autores principales: Peric, Luka, Vukadin, Sonja, Petrovic, Ana, Kuna, Lucija, Puseljic, Nora, Sikora, Renata, Rozac, Karla, Vcev, Aleksandar, Smolic, Martina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775348/
https://www.ncbi.nlm.nih.gov/pubmed/36552021
http://dx.doi.org/10.3390/biomedicines10123265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775348/
https://www.ncbi.nlm.nih.gov/pubmed/36552021
http://dx.doi.org/10.3390/biomedicines10123265

Ejemplares similares